Clinical Trial Update: Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of riluzole and IFB-088 for bulbar amyotrophic lateral sclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• IFB-088
• Riluzole (riluzole)

Snippet

Sponsor: InFlectis BioScience | Conditions: Amyotrophic Lateral Sclerosis, ALS | Phase 2 | Status: COMPLETED | Results posted: 2025-10-10